Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
about
Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with DysregulationPeptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegenerationSynthesis and Screening of a Haloacetamidine Containing Library To Identify PAD4 Selective InhibitorsThe Immune Syntax Revisited: Opening New Windows on Language EvolutionPotential role for PAD2 in gene regulation in breast cancer cells.Citrullination of myofilament proteins in heart failure.Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesisPotential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones.Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells.The Effects of Blast Exposure on Protein Deimination in the BrainCitrulline-modified phage display: a novel high-throughput discovery approach for the identification of citrulline-containing ligands.Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis.Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen.Specific biotinylation and sensitive enrichment of citrullinated peptides.Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitorMass spectrometric identification of citrullination sites and immunohistochemical detection of citrullinated glial fibrillary acidic protein in Alzheimer's disease brains.Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.Citrullinated calreticulin potentiates rheumatoid arthritis shared epitope signaling.Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.Is anti-cyclic citrullinated Peptide antibody a good value biomarker for Alzheimer disease?Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).Citrullination by peptidylarginine deiminase in rheumatoid arthritis.Dual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortexProtein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potentialUpdate on peptidylarginine deiminases and deimination in skin physiology and severe human diseases.Citrullination of glial intermediate filaments is an early response in retinal injuryProtective effect of Cl-amidine against CLP-induced lethal septic shock in miceNETosis in Alzheimer's Disease.Autoantibodies to posttranslational modifications in rheumatoid arthritis.In vivo relevance of citrullinated proteins and the challenges in their detection.The protein arginine deiminases: Structure, function, inhibition, and disease.L-arginine and nitric oxide in CNS function and neurodegenerative diseases.The application of targeted mass spectrometry-based strategies to the detection and localization of post-translational modifications.Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination.PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.Design, synthesis, and biological evaluation of tetrazole analogs of Cl-amidine as protein arginine deiminase inhibitors.
P2860
Q27001595-AD75AA36-BEEF-4F07-8B8B-B3846D8ABBFDQ27023431-58AE1389-9AAB-44EB-AD71-CC514A033D96Q27675108-FF5ACEA6-D630-4BE8-9B02-FE3E5D8E6F29Q28602830-62128A5F-917A-4673-9B0C-F6BAC5E35F01Q28728858-66456338-2E48-4671-A268-2AC24DCE2219Q30670009-2552A869-46C4-4A31-9B31-2236B6181072Q33368998-ECB49192-D768-46C2-80B8-7290C333307CQ33644443-1995D5AA-5647-44B4-BD53-3FF657540661Q33707996-7C8F2C0F-A8EE-4875-B0D1-D3AC26E64950Q33775472-8E3F9F02-98D3-42CB-A428-A904F177E269Q33902573-B2655AB7-D975-4907-B6C0-FFF8B6CE5104Q33907872-E5DE980B-59A4-48AB-AA26-97CD6748C70CQ34027435-92E846AC-D43D-4B32-BE83-99922FADC100Q34413480-68411C52-E143-421A-A203-29C0EE9BE31CQ34586903-390C33A4-AFEC-417B-85FC-0D0A7B60BCAAQ34981387-9EDB5033-BFEF-4F6A-A15A-75271D59F5DCQ35003000-08DA2414-6264-46C9-B683-8FEB2B177A24Q35057027-9A3014EF-1699-4311-88C8-D49274FE2C99Q35696970-05901BB9-72C1-42FA-AC6E-B4F957BCED97Q36010142-F8172F52-FAEE-429D-AFF3-A60452003533Q36098256-FC793E31-1FB7-466D-9C30-F424540F7234Q36640027-EE828B48-F2C6-407A-9E0B-C63D29314252Q36683082-81ECCCE1-9BF6-4500-A2EA-2A231F458B41Q36917723-2BAAB485-C08E-4F94-8977-E5E06B37DE4EQ36933119-DF2D547E-B742-47B0-B87A-E9F8EE1484FAQ36951043-4CFA4207-B267-4A1A-91C0-06FF5011418DQ37063778-F52EB3FF-6EA4-427F-969B-497706B6A53AQ37165601-1C876F5F-DA80-4D95-BADD-BBD382C77279Q37167606-E185AAC1-78FD-4CCE-B6D1-C77CEACA1668Q37292700-BD92C2D5-BEAA-40A3-8DA9-5B77764873A8Q37397289-F4179813-0973-466A-8B15-D51C41CD8F05Q37675611-65CD187C-17AB-4950-BD16-2A1860012045Q37693939-F6C8DB0E-42CB-4C6D-8010-0F9E642A3DFEQ37982673-4255D269-FF6E-415D-B456-873FC51762ECQ38061870-CA5C94E2-F7D9-4556-994F-207171C7BB85Q38134415-63C8AFAA-E096-4583-B5E1-A744CE0D9F67Q38204953-4ACB6048-F0D1-41BD-A986-0CCCC6F8E184Q38456823-5DAD7E39-856A-419C-A4BB-9889C917314AQ38747640-BC147031-BB14-48DD-803A-49D424E7DF8AQ38923181-9EBB694A-3C18-4AE4-A3F4-377080EDF304
P2860
Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Abnormal accumulation of citru ...... ents with Alzheimer's disease.
@ast
Abnormal accumulation of citru ...... ents with Alzheimer's disease.
@en
type
label
Abnormal accumulation of citru ...... ents with Alzheimer's disease.
@ast
Abnormal accumulation of citru ...... ents with Alzheimer's disease.
@en
prefLabel
Abnormal accumulation of citru ...... ents with Alzheimer's disease.
@ast
Abnormal accumulation of citru ...... ents with Alzheimer's disease.
@en
P2093
P356
P1476
Abnormal accumulation of citru ...... ients with Alzheimer's disease
@en
P2093
Hiroaki Asaga
Hiromi Taguchi
Masaharu Hiratsuka
Naoki Maruyama
Narimichi Kimura
Saori Kobayashi
Shigeo Murayama
Takako Ohsawa
Tosifusa Toda
Yuko Saito
P2860
P304
P356
10.1002/JNR.20431
P577
2005-04-01T00:00:00Z